SILVANA DE CASTRO FARIA to Pyrimidines
This is a "connection" page, showing publications SILVANA DE CASTRO FARIA has written about Pyrimidines.
Connection Strength
0.089
-
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes. J Clin Oncol. 2012 Nov 20; 30(33):4161-7.
Score: 0.045
-
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 2007 May 01; 25(13):1753-9.
Score: 0.031
-
CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. AJR Am J Roentgenol. 2004 Dec; 183(6):1619-28.
Score: 0.013